These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17708287)

  • 1. Factors affecting the serum levels of adipokines in Korean male patients with nonalcoholic fatty liver disease.
    Cho YK; Lee WY; Oh SY; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Kim SW; Oh KW; Yun EJ; Oh ES
    Hepatogastroenterology; 2007; 54(77):1512-6. PubMed ID: 17708287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The relationship between serum adiponectin level and serum alanine aminotransferase elevation in Korean male with nonalcoholic fatty liver disease].
    Lee YS; Cho YK; Pae JC; Oh SY; Kang MS; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Lee WY; Oh KW; Yun EJ; Oh ES
    Korean J Hepatol; 2006 Jun; 12(2):221-9. PubMed ID: 16804347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of insulin resistance and adipocytokines on serum alanine aminotransferase in presurgical morbid obese patients.
    de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R; de la Fuente B; Perez Castrillon JL
    Eur Rev Med Pharmacol Sci; 2009; 13(6):413-8. PubMed ID: 20085121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association of serum leptin and insulin resistance with nonalcoholic fatty liver disease].
    Hu ZW; Guo JW; Deng XL
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):853-5. PubMed ID: 16793619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance.
    Baranova A; Gowder SJ; Schlauch K; Elariny H; Collantes R; Afendy A; Ong JP; Goodman Z; Chandhoke V; Younossi ZM
    Obes Surg; 2006 Sep; 16(9):1118-25. PubMed ID: 16989692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH).
    Krawczyk K; Szczesniak P; Kumor A; Jasinska A; Omulecka A; Pietruczuk M; Orszulak-Michalak D; Sporny S; Malecka-Panas E
    J Physiol Pharmacol; 2009 Oct; 60 Suppl 3():71-5. PubMed ID: 19996485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
    Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
    Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Ala54Thr polymorphism of fatty acid-binding protein 2 on histological alterations and insulin resistance of non alcoholic fatty liver disease.
    Aller R; De Luis DA; Fernandez L; Calle F; Velayos B; Izaola O; Gonzalez Sagrado M; Conde R; Gonzalez JM
    Eur Rev Med Pharmacol Sci; 2009; 13(5):357-64. PubMed ID: 19961041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.
    Lemoine M; Ratziu V; Kim M; Maachi M; Wendum D; Paye F; Bastard JP; Poupon R; Housset C; Capeau J; Serfaty L
    Liver Int; 2009 Oct; 29(9):1431-8. PubMed ID: 19422483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects.
    Musso G; Gambino R; Bo S; Uberti B; Biroli G; Pagano G; Cassader M
    Diabetes Care; 2008 Mar; 31(3):562-8. PubMed ID: 18056890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of adipokines in patients with chronic HCV infection: relationship with steatosis and fibrosis.
    Tiftikci A; Atug O; Yilmaz Y; Eren F; Ozdemir FT; Yapali S; Ozdogan O; Celikel CA; Imeryuz N; Tozun N
    Arch Med Res; 2009 May; 40(4):294-8. PubMed ID: 19608019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.
    Yoo J; Lee S; Kim K; Yoo S; Sung E; Yim J
    Diabetes Res Clin Pract; 2008 Sep; 81(3):321-6. PubMed ID: 18571268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between the severity of liver damage and the serum leptin level for nonalcoholic fatty liver disease].
    Kim KO; Park SH; Park CH; Han TH; Yoo KS; Kim JH; Lee MS; Kim DJ; Park CK; Cho HD
    Korean J Hepatol; 2005 Mar; 11(1):51-8. PubMed ID: 15788885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current status of liver disease in Korea: nonalcoholic fatty liver disease.
    Park SH
    Korean J Hepatol; 2009 Dec; 15 Suppl 6():S34-9. PubMed ID: 20037278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
    Wu H; Jia W; Bao Y; Lu J; Zhu J; Wang R; Chen Y; Xiang K
    Diabetes Res Clin Pract; 2008 Feb; 79(2):185-90. PubMed ID: 17904683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adipokines influencing metabolic and cardiovascular disease are differentially regulated in maintenance hemodialysis.
    Ziegelmeier M; Bachmann A; Seeger J; Lossner U; Kratzsch J; Blüher M; Stumvoll M; Fasshauer M
    Metabolism; 2008 Oct; 57(10):1414-21. PubMed ID: 18803947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum leptin level can be a negative marker of hepatocyte damage in nonalcoholic fatty liver.
    Serin E; Ozer B; Gümürdülü Y; Kayaselçuk F; Kul K; Boyacioğlu S
    J Gastroenterol; 2003; 38(5):471-6. PubMed ID: 12768390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum adiponectin, leptin, resistin and RBP4 levels in obese and metabolic syndrome children with nonalcoholic fatty liver disease.
    Boyraz M; Cekmez F; Karaoglu A; Cinaz P; Durak M; Bideci A
    Biomark Med; 2013 Oct; 7(5):737-45. PubMed ID: 24044566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Leptin to adiponectin ratio, as an index of insulin resistance and atherosclerosis development].
    Kieć-Klimczak M; Malczewska-Malec M; Huszno B
    Przegl Lek; 2008; 65(12):844-9. PubMed ID: 19441676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trans fat intake lowers total cholesterol and high-density lipoprotein cholesterol levels without changing insulin sensitivity index in Wistar rats.
    Huang Z; Wang B; Pace RD; Yoon S
    Nutr Res; 2009 Mar; 29(3):206-12. PubMed ID: 19358935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.